The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DNA Brands are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak
Strong
Over the last 90 days DNA Brands has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, DNA Brands is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Price Earnings Ratio
0.15
Total Cashflows From Investing Activities
1000 K
DNA
DNA Brands Relative Risk vs. Return Landscape
If you would invest 0.01 in DNA Brands on April 27, 2025 and sell it today you would earn a total of 0.00 from holding DNA Brands or generate 0.0% return on investment over 90 days. DNA Brands is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than DNA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
DNA Brands Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNA Brands' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as DNA Brands, and traders can use it to determine the average amount a DNA Brands' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
DNAX
Based on monthly moving average DNA Brands is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DNA Brands by adding DNA Brands to a well-diversified portfolio.
DNA Brands Fundamentals Growth
DNA Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of DNA Brands, and DNA Brands fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DNA Pink Sheet performance.
Evaluating DNA Brands' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if DNA Brands has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DNA Brands has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Things to note about DNA Brands performance evaluation
Checking the ongoing alerts about DNA Brands for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for DNA Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
DNA Brands generated a negative expected return over the last 90 days
DNA Brands has some characteristics of a very speculative penny stock
DNA Brands currently holds 2 M in liabilities. DNA Brands has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist DNA Brands until it has trouble settling it off, either with new capital or with free cash flow. So, DNA Brands' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DNA Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DNA to invest in growth at high rates of return. When we think about DNA Brands' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 249.01 K. Net Loss for the year was (1.25 M) with profit before overhead, payroll, taxes, and interest of 249.01 K.
DNA Brands currently holds about 499 in cash with (1.1 M) of positive cash flow from operations.
Evaluating DNA Brands' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate DNA Brands' pink sheet performance include:
Analyzing DNA Brands' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DNA Brands' stock is overvalued or undervalued compared to its peers.
Examining DNA Brands' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating DNA Brands' management team can have a significant impact on its success or failure. Reviewing the track record and experience of DNA Brands' management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of DNA Brands' pink sheet. These opinions can provide insight into DNA Brands' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating DNA Brands' pink sheet performance is not an exact science, and many factors can impact DNA Brands' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.